AURX
Tesseract Medical Research, LLC
Application Filed: 2016-11-14
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87235356 |
| Registration Number | 5413895 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Kim R. Pearson |
| Law Office Assigned | M10 |
| Employee Name | BLOHM, LINDA E |
Timeline
| 2016-11-14 | Application Filed |
| 2017-07-17 | Date of First Use |
| 2017-08-15 | Published for Opposition |
| 2018-01-19 | Location: PUBLICATION AND ISSUE SECTION |
| 2018-02-27 | Status: Live/Registered |
| 2018-02-27 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Tesseract Medical Research, LLC |
| Address | 1370 Trancas Street, Suite 350 Napa DE 94558 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing short-chain fatty acids in single molecule form with a release agent that enhances solubility and absorption; nutritional ingredients, namely, a blend of nutrients, namely, short-chain fatty acids in single molecule form with a release agent that ensures solubility and absorption, that are an integral component of medicals foods, for short-chain fatty acid deficiencies in individuals with Autism Spectrum Disorder; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations to mitigate short-chain fatty acid microbiome deficiencies in individuals with Autism Spectrum Disorder; dietary supplements for restoring health in individuals with diseases, disorders, nutritional deficiencies, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, namely, increasing butyric acid and acetic acid in the gastrointestinal tract; functional nutrients containing butyric acid and acetic acid to mitigate short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; pharmaceutical preparations to mitigate short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; specialty nutraceuticals for the dietary management of diseases, disorders, and nutritional deficiencies, namely, short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder and deficiencies of butyrate in the gastrointestinal tract |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2016-11-17 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-11-18 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-02-21 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2017-02-21 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-02-21 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-02-21 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-03-30 | 7 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2017-04-13 | 8 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-04-20 | 9 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-04-20 | 10 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2017-05-06 | 11 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-05-06 | 12 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-05-06 | 13 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-06-26 | 14 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-06-26 | 15 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-06-27 | 16 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2017-07-11 | 17 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2017-07-11 | 18 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-07-11 | 19 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2017-07-11 | 20 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-07-11 | 21 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-07-26 | 22 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-08-15 | 23 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-08-15 | 24 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-10-10 | 25 NOAM E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2017-12-27 | 26 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2018-01-12 | 27 AITU A:Allowance for Publication |
| USE AMENDMENT FILED | 2017-12-27 | 28 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2018-01-13 | 29 SUPC I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2018-01-19 | 30 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2018-01-20 | 31 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2018-02-27 | 32 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2023-02-27 | 33 REM1 E:E-Mail |
| TEAS SECTION 8 RECEIVED | 2024-04-02 | 34 ES8R I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 AURX 87235356 5413895 Live/Registered |
Tesseract Medical Research, LLC 2016-11-14 |
 AURX 75560574 not registered Dead/Abandoned |
AuRx, Inc. 1998-09-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 